
Amneal Biosciences:
Founded on
a passion for
helping patients
It’s all about value
We are focused on providing high-quality, affordable medicines

1994: Discovering
Starting as a pharmacist, Amneal co-founder, Chintu Patel, discovered a new purpose.

“Patients shouldn’t have to choose between
affording food or medicine.”

2002: Establishing
Chintu teamed up with his brother, Chirag, to found Amneal Pharmaceuticals.

2005: Manufacturing
Amneal produces its first generic prescription drug.

2006-2011: Building
Amneal becomes one of the largest generics companies in the United States.

2014: Evolving
Amneal Biosciences* is formed.

“Our high-quality, affordable biosimilar options enhance the
sustainability of the oncology supply chain.”

2018: Initial Public Offering
The Amneal IPO in May 2018 provided the foundation for continued growth and innovation.

2022: Emerging
Our biosimilar products help to create a more sustainable healthcare system by offering affordable and high-quality treatment options.
*Amneal Biosciences is a division within Amneal’s Generics segment, which is a part of Amneal Pharmaceuticals LLC.
Hear from the founders about how Amneal Biosciences grew from humble beginnings into the global leader of affordable, sophisticated medicines it is today.
